Ftse Mib
34.199,20
-0,28%
DAX
18.057,24
-0,41%
S&P 500
5.116,17
0,32%
NASDAQ Composite
15.983,08
0,35%
Bitcoin
61.318,34
-3,95%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cerevel Therapeutics Holdings Inc (CERE) Cerevel Therapeutics Holdings Inc (CERE) Notizie

Cerevel Therapeutics Holdings Inc

CERE
42,75
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 13:10:07
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/4/202412:30GLOBECerevel Therapeutics Announces Positive Topline Results for..
27/2/202422:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
16/2/202422:46EDGAR2Form 8-K - Current report
09/2/202415:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/2/202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202414:30PRNUSKuehn Law Encourages MDC, WAVD, NS and CERE Investors to..
23/1/202423:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202413:44EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
18/1/202413:19EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
05/1/202423:13EDGAR2Form PREM14A - Preliminary proxy statements relating to..
03/1/202400:10PRNUSKuehn Law Encourages CERE, HA, IMGN, and WAVD Investors to..
28/12/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202323:03EDGAR2Form 144 - Report of proposed sale of securities
22/12/202302:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202302:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202302:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202302:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202302:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:34EDGAR2Form 144 - Report of proposed sale of securities
11/12/202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202323:00EDGAR2Form SC 13D/A - General statement of acquisition of..
08/12/202312:23IHMARKETNEWSApple Boosts Vietnam Production, Broadcom Revenue Miss,..
08/12/202301:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202322:32EDGAR2Form 144 - Report of proposed sale of securities
07/12/202322:31EDGAR2Form 144 - Report of proposed sale of securities
07/12/202314:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/12/202314:00EDGAR2Form 8-K - Current report
07/12/202312:23IHMARKETNEWSAlphabet Unveils Advanced AI Model, AMD Expects $45 Billion..
07/12/202305:24PRNUSCERE MERGER ANNOUNCEMENT: Julie & Holleman LLP Announces..
06/12/202322:30PRNUSAbbVie to Acquire Cerevel Therapeutics in Transformative..
06/12/202300:42EDGAR2Form 144 - Report of proposed sale of securities
29/11/202312:30GLOBECerevel Therapeutics to Host Investor Webcast on Tavapadon..
08/11/202312:30GLOBECerevel Therapeutics to Present at Upcoming Investor..
01/11/202311:39EDGAR2Form 8-K - Current report
01/11/202311:30GLOBECerevel Therapeutics Reports Third Quarter 2023 Financial..
18/10/202322:32EDGAR2Form SC 13D/A - General statement of acquisition of..
13/10/202312:30GLOBECerevel Therapeutics to Report Third Quarter 2023 Financial..
12/10/202322:19EDGAR2Form 8-K - Current report
12/10/202322:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/10/202304:45GLOBECerevel Therapeutics Announces Pricing of $450 Million..
11/10/202322:14EDGAR2Form 8-K - Current report
11/10/202322:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/10/202322:01GLOBECerevel Therapeutics Announces Proposed Public Offering of..
Apertura: Min: Max:
Chiusura: 42,75

La tua Cronologia

NASDAQ
CERE
Cerevel Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network